H.R. 1352 · 118th Congress

Increasing Access to Biosimilars Act of 2023

Stage
Reported from committee
Sponsor
Richard Hudson
Introduced
2023-03-03
Latest action
2024-12-17 · Referred to the Subcommittee on Health.

Action history

  1. 2024-12-17Referred to the Subcommittee on Health.
  2. 2023-12-06Committee Consideration and Mark-up Session Held
  3. 2023-12-06Ordered to be Reported (Amended) by the Yeas and Nays: 44 - 0.
  4. 2023-12-05Committee Consideration and Mark-up Session Held
  5. 2023-11-15Subcommittee Consideration and Mark-up Session Held
  6. 2023-11-15Forwarded by Subcommittee to Full Committee by Voice Vote.
  7. 2023-03-10Referred to the Subcommittee on Health.
  8. 2023-03-03Introduced in House
  9. 2023-03-03Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
  10. 2023-03-03Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.